PYRAZINE MODULATORS OF CANNABINOID RECEPTORS

摘要

The present application describes compounds according to Formula (I), wherein A, G<1>, G<2> and R<1> are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula (I) both alone and in combination with one or more additional therapeutic agents.